Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Adamant Global Biotech

+ Add to Watchlist

ADGLBII:SW

3,200.28 CHF 43.91 1.42%

As of 11:34:00 ET on 01/22/2015.

Snapshot for Adamant Global Biotech (ADGLBII)

Year To Date: -4.69% 3-Month: +1.93% 3-Year: +39.85% 52-Week Range: 2,114.38 - 3,585.79
1-Month: -2.74% 1-Year: +32.88% 5-Year: - Beta vs SMI: 1.17

Mutual Fund Chart for ADGLBII

No chart data available.
  • ADGLBII:SW 3,200.28
  • 1M
  • 1Y
Interactive ADGLBII Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ADGLBII

Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.

Inception Date: 10-15-2010 Telephone: +41 800 850 050
Managers: JOHN MANIERI
Web Site: www.zkb.ch/fonds

Fundamentals for ADGLBII

NAV (on 2015-01-28) 3,200.28
Assets (M) (on 2015-01-28) 150.90
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment -

Dividends for ADGLBII

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ADGLBII

Front Load 1.20
Back Load 1.00
Current Mgmt Fee 1.20
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.24

Top Fund Holdings for ADGLBII

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 134,000 13,202,637 9.567%
Amgen Inc 100,000 12,765,117 9.250%
Celgene Corp 145,000 12,618,490 9.144%
Biogen Idec Inc 34,000 10,681,888 7.741%
Alexion Pharmaceuticals Inc 55,000 8,527,434 6.179%
Illumina Inc 43,000 7,063,475 5.119%
Vertex Pharmaceuticals Inc 73,000 6,255,814 4.533%
Salix Pharmaceuticals Ltd 40,000 5,828,836 4.224%
Regeneron Pharmaceuticals Inc 18,000 5,778,427 4.187%
Isis Pharmaceuticals Inc 140,000 5,226,206 3.787%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil